These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35004678)

  • 21. Role of novel biomarkers in diabetic cardiomyopathy.
    Kumric M; Ticinovic Kurir T; Borovac JA; Bozic J
    World J Diabetes; 2021 Jun; 12(6):685-705. PubMed ID: 34168722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy.
    Ke X; Lin Z; Ye Z; Leng M; Chen B; Jiang C; Jiang X; Li G
    Front Endocrinol (Lausanne); 2021; 12():679655. PubMed ID: 34367065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into DNA methylation and its critical implications in diabetic vascular complications.
    Zheng J; Cheng J; Zhang Q; Xiao X
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28183874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics of diabetic complications.
    Villeneuve LM; Natarajan R
    Expert Rev Endocrinol Metab; 2010 Jan; 5(1):137-148. PubMed ID: 24077653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Western diet given to healthy rats mimics the human phenotype of diabetic cardiomyopathy.
    Verboven M; Deluyker D; Ferferieva V; Lambrichts I; Hansen D; Eijnde BO; Bito V
    J Nutr Biochem; 2018 Nov; 61():140-146. PubMed ID: 30245335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Non-coding RNA in Diabetic Cardiomyopathy.
    Xia L; Song M
    Adv Exp Med Biol; 2020; 1229():181-195. PubMed ID: 32285412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
    Zaveri MP; Perry JC; Schuetz TM; Memon MD; Faiz S; Cancarevic I
    Cureus; 2020 Oct; 12(10):e11100. PubMed ID: 33240696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases.
    Wang B; Shao X; Song R; Xu D; Zhang JA
    Front Immunol; 2017; 8():396. PubMed ID: 28439272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic Modifications in Essential Hypertension.
    Wise IA; Charchar FJ
    Int J Mol Sci; 2016 Mar; 17(4):451. PubMed ID: 27023534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epigenetics of schizophrenia: a review].
    Rivollier F; Lotersztajn L; Chaumette B; Krebs MO; Kebir O
    Encephale; 2014 Oct; 40(5):380-6. PubMed ID: 25127897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
    Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease.
    Xiao X; Liu X; Jiao B
    Front Neurol; 2020; 11():538301. PubMed ID: 33178099
    [No Abstract]   [Full Text] [Related]  

  • 33. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiny molecule, big power: Multi-target approach for curcumin in diabetic cardiomyopathy.
    Karuppagounder V; Arumugam S; Giridharan VV; Sreedhar R; Bose RJ; Vanama J; Palaniyandi SS; Konishi T; Watanabe K; Thandavarayan RA
    Nutrition; 2017 Feb; 34():47-54. PubMed ID: 28063511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
    Jia G; Whaley-Connell A; Sowers JR
    Diabetologia; 2018 Jan; 61(1):21-28. PubMed ID: 28776083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics and Inflammation in Diabetic Nephropathy.
    Shao BY; Zhang SF; Li HD; Meng XM; Chen HY
    Front Physiol; 2021; 12():649587. PubMed ID: 34025445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
    BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of epigenetics in the management of cardiovascular disease: a review.
    Cao Y; Lu L; Liu M; Li XC; Sun RR; Zheng Y; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3097-104. PubMed ID: 25392111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.
    Parim B; Sathibabu Uddandrao VV; Saravanan G
    Heart Fail Rev; 2019 Mar; 24(2):279-299. PubMed ID: 30349977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The limited clinical value of a specific diabetic cardiomyopathy.
    Vigili de Kreutzenberg S; Avogaro A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):599-605. PubMed ID: 23725770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.